Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | QDPR | P09417 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | HTR1A | P08908 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.44 |
| ▸ | HTR6 | P50406 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL8580869 | 0.98 | QDPR (0.49) | QDPRKDM4ELMNAPOLBHTR1A | |
| SCHEMBL31718158 | 0.76 | QDPR (0.63) | QDPR | |
| SCHEMBL50923 | 0.73 | QDPR (0.67) | QDPRKDM4ELMNAPOLBHTR1A | |
| SCHEMBL16862164 | 0.73 | QDPR (0.67) | QDPRKDM4ELMNAPOLBHTR1A | |
| SCHEMBL30877437 | 0.73 | HTR6 (0.50) | LMNAHTR6 | |
| Bromide SCHEMBL11557389 | 0.72 | QDPR (0.65) | QDPRKDM4ELMNAPOLBHTR1A | |
| Hydrochloric Acid SCHEMBL1148906 | 0.72 | QDPR (0.65) | QDPRKDM4ELMNAPOLBHTR1A | |
| Ammonia Solution, Strong SCHEMBL15875021 | 0.72 | QDPR (0.65) | QDPRKDM4ELMNAPOLBHTR1A | |
| Hydrochloric Acid SCHEMBL19717522 | 0.70 | QDPR (0.62) | QDPRKDM4ELMNAPOLBHTR1A | |
| SCHEMBL13898494 | 0.70 | QDPR (0.68) | QDPRKDM4ELMNAPOLBHTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020164744-A1 | Soluble, active recombinant human MAO-B | DEIBEL MARTIN R (US) | 2002-11-07 | — | — | US | claimed |
| EP-1198574-A2 | SOLUBLE, ACTIVE RECOMBINANT HUMAN MAO-B | PHARMACIA & UPJOHN COMPANY (US) | 2002-04-24 | — | — | EP | claimed |
| US-6265178-B1 | Assay for determining oxazolidinone antibiotics having minimum monoamine oxidase inhibitory activity | PHARMACIA & UPJOHN COMPANY | 2001-07-24 | — | — | US | claimed |
| WO-2001011053-A2 | SOLUBLE, ACTIVE RECOMBINANT HUMAN MAO-B | PHARMACIA & UPJOHN COMPANY (US) | 2001-02-15 | — | — | WO | claimed |
| CN-1278817-A | S-oxide and S, S-dioxide tetrahydrothiopyran phenyloxazolidinones | UPJOHN CO (US) | 2001-01-03 | — | — | CN | claimed |
| EP-1036074-A1 | S-OXIDE AND S,S-DIOXIDE TETRAHYDROTHIOPYRAN PHENYLOXAZOLIDINONES | PHARMACIA & UPJOHN COMPANY (US) | 2000-09-20 | — | — | EP | claimed |
| WO-1999029688-A1 | S-OXIDE AND S,S-DIOXIDE TETRAHYDROTHIOPYRAN PHENYLOXAZOLIDINONES | PHARMACIA & UPJOHN COMPANY (US) | 1999-06-17 | — | — | WO | claimed |
| EP-0038003-A2 | Antidepressant pyrrolylpiperidines | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1981-10-21 | — | — | EP | claimed |
| US-4267185-A | SAID PYRROLYLPIPERIDINES BEING 1,2,3,6-TETRAHYDRO-1-METHYL-4-(1-METHYLPYRROL-2-YL)PYRIDINE OR 1-METHYL-4-(1-METHYLPYRROL-2-YL)-4-PIPERIDINOL | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1981-05-12 | — | — | US | claimed |
| US-20110067123-A1 | MAO-B ELEVATION AS AN EARLY PARKINSON'S DISEASE BIOMARKER | BUCK INSTITUTE FOR AGE RESEARCH | 2011-03-17 | — | — | US | disclosed |
| WO-2009105481-A1 | MAO-B ELEVATION AS AN EARLY PARKINSON'S DISEASE BIOMARKER | THE BUCK INSTITUTE FOR AGE RESEARCH (US) | 2009-08-27 | — | — | WO | disclosed |
| US-7435751-B2 | 7-Fluoro-1,3-dihydro-indol-2-one oxazolidinones as antibacterial agents | JOSYULA VARA PRASAD VENKATA NAGENDRA | 2008-10-14 | — | — | US | disclosed |
| EP-1869029-A1 | AN OXINDOLE OXAZOLIDINONE AS ANTIBACTERIAL AGENT | Pharmacia & Upjohn Company LLC (US) | 2007-12-26 | — | — | EP | disclosed |
| EP-1869030-A1 | 7-FLUORO-1,3-DIHYDRO-INDOL-2-ONE OXAZOLIDINONES AS ANTIBACTERIAL AGENTS | Pharmacia & Upjohn Company LLC (US) | 2007-12-26 | — | — | EP | disclosed |
| EP-0421762-A1 | Novel nicotine analogs and method | Philip Morris Products Inc. (US) | 1991-04-10 | — | — | EP | disclosed |
| EP-0038003-A3 | ANTIDEPRESSANT PYRROLYLPIPERIDINES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1981-12-16 | — | — | EP | disclosed |
| EP-0038003-A2 | Antidepressant pyrrolylpiperidines | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1981-10-21 | — | — | EP | disclosed |
| EP-0038003-A2 | Antidepressant pyrrolylpiperidines | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1981-10-21 | — | — | EP | disclosed |
| US-4267185-A | SAID PYRROLYLPIPERIDINES BEING 1,2,3,6-TETRAHYDRO-1-METHYL-4-(1-METHYLPYRROL-2-YL)PYRIDINE OR 1-METHYL-4-(1-METHYLPYRROL-2-YL)-4-PIPERIDINOL | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1981-05-12 | — | — | US | disclosed |
| US-4267185-A | SAID PYRROLYLPIPERIDINES BEING 1,2,3,6-TETRAHYDRO-1-METHYL-4-(1-METHYLPYRROL-2-YL)PYRIDINE OR 1-METHYL-4-(1-METHYLPYRROL-2-YL)-4-PIPERIDINOL | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1981-05-12 | — | — | US | disclosed |